Retinoic Acid, also known as Tretinoin or All-Trans Retinoic Acid (ATRA), is a powerful derivative of Vitamin A that has revolutionized treatments in both dermatology and oncology. As a Pharmaceutical Intermediate, its high purity of over 99% makes it an indispensable ingredient for a wide range of therapeutic applications. This article delves into the remarkable versatility of Retinoic Acid, highlighting its journey from managing common skin concerns to its critical role in combating life-threatening diseases.

In the realm of dermatology, Retinoic Acid is renowned for its efficacy in treating various skin conditions. It is a cornerstone in the treatment of acne vulgaris, effectively unclogging pores, reducing inflammation, and promoting cell turnover to reveal clearer skin. Beyond acne, it also addresses conditions like keratosis pilaris, improving skin texture and appearance. The pharmaceutical grade quality ensures that formulations leveraging this ingredient are potent and reliable for dermatological use.

However, the significance of Retinoic Acid extends far beyond cosmetic applications. Its most profound impact has been observed in the field of oncology, particularly in the treatment of Acute Promyelocytic Leukemia (APL). APL is a subtype of leukemia characterized by a specific chromosomal abnormality that often involves the retinoic acid receptor gene. Retinoic Acid works by inducing the differentiation of leukemic cells, effectively pushing them towards maturation and thereby halting their uncontrolled proliferation. This groundbreaking application has transformed the prognosis for APL patients, making Retinoic Acid a life-saving medication.

When seeking Retinoic Acid, it is crucial to prioritize purity and grade. Sourcing from a reputable manufacturer ensures that you receive a product that meets stringent quality standards, vital for both therapeutic efficacy and patient safety. The availability of Retinoic Acid as a yellow powder with a shelf life of 2 years makes it a stable and accessible ingredient for pharmaceutical formulations. Understanding the CAS number, 302-79-4, is also important for product identification and quality assurance.

For those involved in pharmaceutical development or medical treatment, securing a consistent supply of high-quality Retinoic Acid is paramount. Its dual role in treating persistent skin conditions and managing aggressive cancers underscores its importance in modern medicine. As a key Pharmaceutical Intermediate, Retinoic Acid continues to be a subject of extensive research, promising further advancements in therapeutic strategies.